• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL ENTERPRISE2 4MMX23MM; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL ENTERPRISE2 4MMX23MM; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number ENCR402312
Device Problem Activation Failure (3270)
Patient Problem Transient Ischemic Attack (2109)
Event Date 01/07/2022
Event Type  Injury  
Event Description
It was reported by a healthcare professional that a (b)(6) female patient underwent stent-assisted coil embolization of a 3.08mm x 3.2mm (3.3mm neck size) left internal carotid artery (ica) (c6 segment) aneurysm with a 4mm x 23mm enterprise 2 stent (encr402312/6610167) and experienced incomplete stent expansion during the procedure.The stent was semi-released and covered the aneurysm neck; after the aneurysm was embolized with coils, the stent was completely released.However, it was found that the proximal markers of the stent were not completely deployed.It was reported that the intracranial artery was ischemic due to the event.The patient was subsequently given aspirin and clopidogrel.She was then transferred to the intensive care unit (icu) in stable condition.Additional information received indicated that the patient has since been discharged from the hospital.The patient had left ica stenosis of the c5-c6 segments at baseline.Additional information received indicated that the event resulted in cerebral ischemia; the event was diagnosed by the physician.The physician used a microcatheter to massage the stent in an attempt to open/expand the stent.The event did not lead to stent migration or embolization.It is unknown whether the enterprise was patent after the event.The proximal diameter of the parent artery was 2.6mm and the distal diameter of the parent artery was 3.8mm.It was reported that vessel calcification may have contributed to the incomplete stent expansion.The patient does not have any residual symptoms.The temperature indicator label on the inner pouch had been checked and found to be within acceptable criteria.There was no resistance felt during advancement of the device.The stent did not appear to be damaged.There was no evidence of coil protrusion into the parent vessel.No further information was provided.
 
Manufacturer Narrative
Product complaint #(b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Initial reporter: the customer contact information, including name, occupation, phone, fax, and e-mail address, was not reported.The device was implanted; therefore, no further investigation can be performed.(b)(4) medical did review the device history records relative to the manufacturing, inspecting and packaging of the lot 6610167.The history records indicate this product was final inspection tested at lake region medical and was determined to be acceptable.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.Complaint conclusion: it was reported by a healthcare professional that a 66-year-old female patient underwent stent-assisted coil embolization of a 3.08mm x 3.2mm (3.3mm neck size) left internal carotid artery (ica) (c6 segment) aneurysm with a 4mm x 23mm enterprise 2 stent ((b)(6)) and experienced incomplete stent expansion during the procedure.The stent was semi-released and covered the aneurysm neck; after the aneurysm was embolized with coils, the stent was completely released.However, it was found that the proximal markers of the stent were not completely deployed.It was reported that the intracranial artery was ischemic due to the event.The patient was subsequently given aspirin and clopidogrel.She was then transferred to the intensive care unit (icu) in stable condition.Additional information received indicated that the patient has since been discharged from the hospital.The patient had left ica stenosis of the c5-c6 segments at baseline.Additional information received indicated that the event resulted in cerebral ischemia; the event was diagnosed by the physician.The physician used a microcatheter to massage the stent in an attempt to open/expand the stent.The event did not lead to stent migration or embolization.It is unknown whether the enterprise was patent after the event.The proximal diameter of the parent artery was 2.6mm and the distal diameter of the parent artery was 3.8mm.It was reported that vessel calcification may have contributed to the incomplete stent expansion.The patient does not have any residual symptoms.The temperature indicator label on the inner pouch had been checked and found to be within acceptable criteria.There was no resistance felt during advancement of the device.The stent did not appear to be damaged.There was no evidence of coil protrusion into the parent vessel.No further information was provided.Returned medical imaging was reviewed by neurointerventionalist, the assessment reads as follows: "the case is supported by video footage which shows a coiled aneurysm in the pcom region with a supporting enterprise stent.The stent is nicely opened in the distal portion but the proximal part of the stent lands too proximal in a perpendicular direction to the arterial wall due to the curve in the internal carotid artery at that point.Several attempts of the physician to open the stent are visible but did not result in proper opening, due to the fact that the laser-cut stent does not foreshorten upon pressure, unlike braided stents.The position of the proximal end of the stent is therefore unchanged, ending into the arterial wall, without possibility to further open up." lake region medical did review the device history records relative to the manufacturing, inspecting and packaging of the lot 6610167.The history records indicate this product was final inspection tested at lake region medical and was determined to be acceptable.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Therefore, no corrective action is warranted at this time.Incomplete stent expansion and cerebral ischemia are known potential complications associated with the enterprise 2 vascular reconstruction device (vrd) and are listed in the instructions for use (ifu) as such.With the information provided and without the return of the complaint device, it is not possible to determine the root cause of the event.However, there are clinical and procedural factors including aneurysm/vessel characteristics, device selection, and operator technique that may have contributed rather than the design or manufacture of the device.The alleged incomplete stent expansion resulted in cerebral ischemia with the need for medical and surgical intervention (i.E., use of a microcatheter to massage the stent).The file will be re-reviewed if additional information is received at a later date.As part of the cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENTERPRISE2 4MMX23MM
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key13366422
MDR Text Key288663958
Report Number3008114965-2022-00067
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/27/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberENCR402312
Device Lot Number6610167
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/06/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/21/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexFemale
-
-